Global Herpes Treatment Market 2017-2021

  • ID: 4312787
  • Report
  • Region: Global
  • 82 pages
  • TechNavio
OFF
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 5

FEATURED COMPANIES

  • Abbott
  • Agenus
  • Genocea
  • Gilead
  • GlaxoSmithKline
  • Merck
  • MORE
Herpesviruses belong to double-stranded DNA viruses, which are responsible for a large number of diseases in humans and animals. There are eight types of human herpesvirus (HHV) that affects humans. Among these, herpes simplex virus (HSV) and varicella-zoster virus (VZV) are the two most commonly found HHVs that causes severe infections in humans. HSV is further segmented into oral herpes and genital herpes.

The report forecasts that the global herpes treatment market to grow at a CAGR of 12.97% during the period 2017-2021.

Covered in this report:

The report covers the present scenario and the growth prospects of the global herpes treatment market for 2017-2021. To calculate the market size, the report considers the sales of both branded and generic drugs in herpes treatment market.

The market is divided into the following segments based on geography:
  • Americas
  • APAC
  • EMEA
This report, Global Herpes Treatment Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion operating in this market.

Key vendors:
  • Gilead
  • GlaxoSmithKline
  • Merck
  • Novartis
Other prominent vendors:
  • Abbott
  • Agenus
  • Genocea
  • Mylan
  • Teva Pharmaceutical Industries
  • Vical
Market drivers:
  • Increasing prevalence of herpes infection
  • For a full, detailed list, view this report
Market challenges:
  • Side effects of drugs
  • For a full, detailed list, view this report
Market trends:
  • Emergence of novel therapies
  • For a full, detailed list, view this report
Key questions answered in this report:
  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?
You can request one free hour of the analyst’s time when you purchase this market report. Details are provided within the report.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Abbott
  • Agenus
  • Genocea
  • Gilead
  • GlaxoSmithKline
  • Merck
  • MORE
Part 01: Executive summary

Part 02: Scope of the report

Part 03: Research Methodology

Part 04: Introduction
  • Market outline
  • Disease overview
Part 05: Market introduction
  • Market overview
  • Market size and forecast
  • Five forces analysis
Part 06: Pipeline landscape

Part 07: Market segmentation by virus type
  • Herpes simplex
  • Herpes zoster
Part 08: Geographical segmentation
  • Herpes treatment market in Americas
  • Herpes treatment market in EMEA
  • Herpes treatment market in APAC
Part 09: Key leading count

Part 10: Drivers and challenges
  • Market drivers
  • Market challenges
Part 11: Market trends
  • Emergence of novel therapies
  • Increasing focus on vaccine development
  • Increasing focus on drug development for pre-adolescent patients
Part 12: Vendor landscape
  • Competitive scenario
Part 13: Key vendor analysis
  • Gilead
  • GlaxoSmithKline
  • Merck
  • Novartis
  • Other prominent vendors
Part 14: Appendix

List of abbreviations

List of Exhibits
Exhibit 01: Types of HHV
Exhibit 02: Symptoms of herpesvirus infection
Exhibit 03: Diagnosis and treatment of herpes
Exhibit 04: Global herpes treatment market snapshot
Exhibit 05: Global herpes treatment market 2016-2021 ($ millions)
Exhibit 06: Opportunity analysis: Global herpes treatment market
Exhibit 07: Five forces analysis
Exhibit 08: Key pipeline molecules by vendors
Exhibit 09: Key clinical trials
Exhibit 10: Global herpes treatment market by virus type
Exhibit 11: Global HSV treatment market
Exhibit 12: Market overview: Global HSV treatment market
Exhibit 13: Global oral herpes treatment market 2016-2021 ($ millions)
Exhibit 14: Global share of HSV-2 infection
Exhibit 15: Global genital herpes treatment market 2016-2021 ($ millions)
Exhibit 16: Global herpes zoster treatment market 2016-2021 ($ millions)
Exhibit 17: Segmentation of global herpes treatment market by geography 2016 and 2021
Exhibit 18: Global herpes treatment market revenue by geography 2016-2021 ($ millions)
Exhibit 19: Market scenario in Americas
Exhibit 20: Herpes treatment market in Americas 2016-2021 ($ millions)
Exhibit 21: Market scenario in EMEA
Exhibit 22: Herpes treatment market in EMEA 2016-2021 ($ millions)
Exhibit 23: Market scenario of APAC
Exhibit 24: Herpes treatment market in APAC 2016-2021 ($ millions)
Exhibit 25: Population at a higher risk of herpes
Exhibit 26: Percentage distribution of organ transplants in US 1988-2016
Exhibit 27: Competitive structure analysis of global herpes treatment market 2016
Exhibit 28: Strategic success factors of companies in global herpes treatment market
Exhibit 29: Gilead: Key highlights
Exhibit 30: Gilead: Strength assessment
Exhibit 31: Gilead: Strategy assessment
Exhibit 32: Gilead: Opportunity assessment
Exhibit 33: GlaxoSmithKline: Key highlights
Exhibit 34: GlaxoSmithKline: Strength assessment
Exhibit 35: GlaxoSmithKline: Strategy assessment
Exhibit 36: GlaxoSmithKline: Opportunity assessment
Exhibit 37: Merck: Key highlights
Exhibit 38: Merck: Strength assessment
Exhibit 39: Merck: Strategy assessment
Exhibit 40: Merck: Opportunity assessment
Exhibit 41: Novartis: Key highlights
Exhibit 42: Novartis: Strength assessment
Exhibit 43: Novartis: Strategy assessment
Exhibit 44: Novartis: Opportunity assessment
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Abbott
  • Agenus
  • Genocea
  • Gilead
  • GlaxoSmithKline
  • Merck
  • MORE
New Research Report - Global Herpes Treatment Market 2017-2021

Other Prominent Vendors in the market are: Abbott, Agenus, Genocea, Mylan, Teva Pharmaceutical Industries, and Vical.

Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is emergence of novel therapies. High dependency on a limited number of therapies is a major challenge being faced by the herpes treatment market. For instance, genital and oral herpes at present do not have any cure; the disease can only be managed by the available treatment options. Several studies are under trial and emergence of better therapies are expected in the coming times. The major drugs present for the treatment of genital herpes control the outbreaks of the disease but not the shedding.”

According to the report, one of the major drivers for this market is increasing prevalence of herpes infection. Apart from traditional risk factors such as sexual or physical contact with the infected person, there have been several other factors contributing to the rising prevalence of herpes. People with the weaker immune system due to the intake of immunosuppressants for an organ transplant are vulnerable to herpes infection and is one of the major factors for increasing prevalence of herpes. The immunocompromised status is assumed to be more vulnerable to catch this viral infection.

Further, the report states that one of the major factors hindering the growth of this market is Side effects of drugs. Lack of complete remission of herpes infection is a huge concern as most of the drugs taken by the herpes-infected patients are for symptomatic relief. This combined with the side effects associated with the usage of the drug lead to less patient adherence, thereby, posing as a growth hurdle. To further aid to this, suppressive therapy is suggested by the doctors, if a person sees frequent outbreaks of the infection.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 5
  • Gilead
  • GlaxoSmithKline
  • Merck
  • Novartis
  • Abbott
  • Agenus
  • Genocea
  • Mylan
  • Teva Pharmaceutical Industries
  • Vical.
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll